WO2024003942 - AN IMPROVED PROCESS FOR THE PREPARATION OF SELUMETINIB SULFATE

National phase entry is expected:
Publication Number WO/2024/003942
Publication Date 04.01.2024
International Application No. PCT/IN2023/050628
International Filing Date 28.06.2023
Title [English] AN IMPROVED PROCESS FOR THE PREPARATION OF SELUMETINIB SULFATE [French] PROCÉDÉ AMÉLIORÉ DE PRÉPARATION DE SULFATE DE SÉLUMÉTINIB
Applicants ** NATCO PHARMA LIMITED Natco House, Road No. 2 Banjara Hills. Hyderabad 500034, IN
Inventors ** KRISHNAMMAGARI, Suresh Kumar Natco House, Road No. 2 Banjara Hills. Hyderabad 500034, IN CHINTALAPATI, Srinivasa Chary Natco House, Road No. 2 Banjara Hills. Hyderabad 500034, IN THOOTA, Sandeep Kumar Natco House, Road No. 2 Banjara Hills. Hyderabad 500034, IN BAREDDY, Vishnu Vardhan Reddy Natco House, Road No. 2 Banjara Hills. Hyderabad 500034, IN KADARI, Ushaiah Natco House, Road No. 2 Banjara Hills. Hyderabad 500034, IN PEDDI, Rajasekhara Reddy Natco House, Road No. 2 Banjara Hills. Hyderabad 500034, IN ABAYEE KALIYAPERUMAL, Srinivasan Natco House, Road No. 2 Banjara Hills. Hyderabad 500034, IN MUDDASANI, Pulla Reddy Natco House, Road No. 2 Banjara Hills. Hyderabad 500034, IN NANNAPANENI, Venkaiah Chowdary Natco House, Road No. 2 Banjara Hills. Hyderabad 500034, IN
Priority Data 202241037974  01.07.2022  IN
Application details
International Searching Authority
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country Stages Total
China Filing 910
EPO Filing, Examination 6314
Japan Filing 574
South Korea Filing 576
USA Filing, Examination 2635
MasterCard Visa
Total: 11009
Abstract [English] The present invention relates to an improved process for the preparation of 5 Selumetinib sulfate of Formula-(I). [French] La présente invention concerne un procédé amélioré pour la préparation de sulfate de sélumétinib de formule (I).